These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7834917)

  • 21. Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis.
    Grzegorzewska AE; Mariak I
    Adv Perit Dial; 2001; 17():5-9. PubMed ID: 11510296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
    Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S
    Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of parathyroid hormone (PTH) and 24,25-dihydroxy-vitamin D3 on adenylyl cyclase of iliac crest biopsies: diagnostic and prognostic tool for evaluation and treatment of uremic patients.
    Gordeladze JO; Mortensen B; Nordal K; Halse J; Dahl E; Aksnes L; Gautvik KM
    Scand J Clin Lab Invest Suppl; 1987; 186():13-20. PubMed ID: 3496656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocytic subpopulation changes after open and laparoscopic cholecystectomy: a prospective and comparative study on 38 patients.
    Cristaldi M; Rovati M; Elli M; Gerlinzani S; Lesma A; Balzarotti L; Taschieri AM
    Surg Laparosc Endosc; 1997 Jun; 7(3):255-61. PubMed ID: 9194291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study.
    Melamed ML; Eustace JA; Plantinga LC; Jaar BG; Fink NE; Parekh RS; Coresh J; Yang Z; Cantor T; Powe NR
    Nephrol Dial Transplant; 2008 May; 23(5):1650-8. PubMed ID: 18065788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hormone replacement therapy on CD4+ and CD8+ numbers, CD4+/CD8+ ratio, and immunoglobulin levels in hemodialysis patients.
    Dogan E; Erkoc R; Demir C; Sayarlioglu H; Dilek I; Sayarlioglu M
    Ren Fail; 2005; 27(4):421-4. PubMed ID: 16060130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Change in T cell-mediated immunity and its relationship with high mobility group box-1 protein levels in extensively burned patients].
    Dong N; Jin BQ; Yao YM; Yu Y; Cao YJ; He LX; Chai JK; Sheng ZY
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(10):759-62. PubMed ID: 18953932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Abnormalities of cellular immunity in uremic patients].
    Matsumoto Y
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):733-42. PubMed ID: 8377286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of CD4+ and CD8+ T-lymphocytes in bone marrow associated with reduced erythropoiesis in patients with chronic inflammation and anaemia.
    Neidhart M; Brühlmann P; Gay S; Michel BA
    Schweiz Med Wochenschr; 1998 Oct; 128(42):1618-23. PubMed ID: 9824895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Investigation of interleukin 2 receptor and T cell subsets in the patients with tuberculous meningitis].
    Zhang SF
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):198-9, 253. PubMed ID: 1307509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia.
    Avram MM; Feinfeld DA; Huatuco AH
    N Engl J Med; 1978 May; 298(18):1000-3. PubMed ID: 205786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 1,25-dihydroxyvitamin D3 in vivo on circulating T lymphocytes.
    Bargman JM; Silverman ED; Klein MH
    Miner Electrolyte Metab; 1989; 15(6):359-64. PubMed ID: 2615722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemodialysis, continuous ambulatory peritoneal dialysis and cellular immunity.
    Collart F; Tielemans C; Dratwa M; Schandene L; Wybran J; Dupont E
    Proc Eur Dial Transplant Assoc; 1983; 20():190-4. PubMed ID: 6228939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parathyroid hormone, a uremic toxin.
    Rodriguez M; Lorenzo V
    Semin Dial; 2009; 22(4):363-8. PubMed ID: 19708982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous ambulatory peritoneal dialysis and cellular immunity.
    Giangrande A; Cantù P; Limido A; de Francesco D; Malacrida V
    Proc Eur Dial Transplant Assoc; 1983; 19():372-9. PubMed ID: 6603616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction by cimetidine of serum parathyroid hormone levels in uremic patients.
    Jacob AI; Lanier D; Canterbury J; Bourgoignie JJ
    N Engl J Med; 1980 Mar; 302(12):671-4. PubMed ID: 7354765
    [No Abstract]   [Full Text] [Related]  

  • 37. Parathyroid hormone-related peptide plasma concentrations in patients on hemodialysis.
    Nordholm A; Rix M; Olgaard K; Lewin E
    Scand J Clin Lab Invest; 2014 Apr; 74(3):206-12. PubMed ID: 24456420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of impaired T cell function in hemodialysis patients: potential role for secondary hyperparathyroidism.
    Alexiewicz JM; Gaciong Z; Klinger M; Linker-Israeli M; Pitts TO; Massry SG
    Am J Nephrol; 1990; 10(6):495-501. PubMed ID: 2075908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cimetidine and circulating calciotropic hormone levels in uremic patients: evidence for a suppressive effect on calcitonin secretion.
    Sebert JL; Decourcelles PH; Morinière P; Calmette C; Gueris J; Makdassi R; Khassouf J; Andrejak M; Fournier A
    Miner Electrolyte Metab; 1982 Dec; 8(6):293-9. PubMed ID: 7167135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The peripheral T and B lymphocytes in uremic patients.
    Sobczyk J
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):681-6. PubMed ID: 317640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.